Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast. - ppt download
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601 | Journal of Clinical Oncology
Endpoints in adjuvant trials: a systematic review of the literature in colon cancer and proposed definitions for future trials Marc E. Buyse. - ppt download
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Survival in oncology reimbursement decision-making | CMAR
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Cancer Research and Treatment
Measures of Cancer Survival
CDISC SDTM and ADaM for survival data - ppt download
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis - The
Time to second subsequent therapy as an endpoint. Progression-free... | Download Scientific Diagram
Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials - London - 2017 - Cancer - Wiley
Basics of survival statistics for oncologists Mehta A, Sharma A - J Curr Oncol
Frontiers | What Is Long-Term Survival and Which First-Line Immunotherapy Brings Long-Term Survival for Advanced Wild-Type Non-Small Cell Lung Cancer: A Network Meta-Analysis Based on Integrated Analysis
PPT - Overall Survival and Progression-Free Survival PowerPoint Presentation - ID:4064400
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Determining lines of therapy in patients with solid cancers: a proposed new systematic and comprehensive framework | British Journal of Cancer
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials | Radiology: Imaging Cancer
Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials - Matulonis - 2015 - Cancer - Wiley Online Library
Extrapolation from Progression Free Survival to Overall Survival in O…
A) Overall survival (OS) from study entry of all eligible patients... | Download Scientific Diagram
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Clinical Trial Endpoints for Oncology Studies
